Business
Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member
WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. (" Medicure " or the " Company ") ...
About this update from Medicure Inc.
[{"type":"text","content":"Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board MemberWINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. (\"Medicure\" or the \"Company\") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the 2024 Q3 Financial Results on a Conference Call on November 26, 2024 at 8:30 am Eastern Time. The Q3 Financials will be filed after closing November 25, 2024.Medicure also announced today that Kimberly Kramchynsky, a member of the Board of Directors, has resigned for personal reasons, effective November 18, 2024.\"On behalf of the Board and senior leadership team, I would like to thank Kim for her contributions and voice on the Board and we wish her the very best,\" stated Albert Friesen, CEO and Chair of Medicure's Board of Directors.Conference Call Info:Topic: Medicure's Q3 2024 ResultsCall date: Tuesday, November 26, 2024Time: 7:30 AM Central Time (8:30 AM Eastern Time)Toll Free: 1 (888) 506-0062International: 1 (973) 528-0011Participant Access Code: 769525Webcast: This conference call will be webcast live over the internet at the following link: https://www.webcaster4.com/Webcast/Page/2965/51688You may request international country-specific access information by e-mailing the Company in advance. Management will accept and answer questions related to the financial results and operations during the question-and-answer period at the end of the conference call. A recording of the call will be available following the event at the Company's website.About Medicure Inc.Medicure is a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The present focus of the Company is the marketing and distribution of AGGRASTAT® (tirofiban hydrochloride) injection and ZYPITAMAG® (pitavastatin) tablets in the United States, where they are sold through the Company's U.S. subsidiary, Medicure Pharma Inc. Medicure also operates Marley Drug Inc. (\"Marley Drug\"), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug® is committed to improving access...